×
About 1,204 results

ALLMedicine™ Oropharyngeal Cancer Center

Research & Reviews  593 results

Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a natio...
https://doi.org/10.1002/hed.26504
Head & Neck REFERENCES; Su WW, Lee YH et. al.

Oct 13th, 2020 - To assess the impact of treatment delay on survival of oral/oropharyngeal cancer (OSCC). We followed 5743 OSCCs between 2004 and 2009 from a population-based screening program and ascertained death until the end of 2012. The hazard ratios (HRs) of...

Prognostic potential of mid-treatment nodal response in oropharyngeal squamous cell car...
https://doi.org/10.1002/hed.26467
Head & Neck REFERENCES; Byun DJ, Tam MM et. al.

Sep 23rd, 2020 - We examine the prognostic implications of mid-course nodal response in oropharyngeal cancer (OPX) to radiation therapy. In 44 patients with node-positive OPX undergoing concurrent chemoradiation, nodal volumes were measured on cone beam CTs from d...

Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwi...
https://doi.org/10.1002/hed.26481
Head & Neck REFERENCES; Clark CM, Newark AC et. al.

Sep 22nd, 2020 - Single-institution studies suggest that aspirin reduces the risk of death in head and neck cancer. The aim of this study was to investigate the effect of aspirin use on overall survival (OS) in veterans with oropharyngeal cancer (OPC). A total of ...

Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous...
https://doi.org/10.1111/odi.13639
Oral Diseases REFERENCES; Bin-Alee F, Arayataweegool A et. al.

Sep 6th, 2020 - To investigate the gene expression profile of peripheral blood mononuclear cells (PBMCs) from head and neck squamous cell carcinoma (HNSCC), including oral cancer (OC) and oropharyngeal cancer (OPC) patients, and compare them with healthy controls...

Phase II study of de-intensified intensity-modulated radiotherapy and concurrent carbop...
https://doi.org/10.1002/hed.26401
Head & Neck REFERENCES; Bahig H, Lambert L et. al.

Aug 31st, 2020 - To assess cancer control and patient-reported outcomes (PROs) after de-intensified intensity-modulated radiotherapy (IMRT) in lateralized p16-associated oropharyngeal cancer (p16-OPC). Lateralized p16-OPC treated with radiotherapy and concurrent C...

see more →

Clinicaltrials.gov  605 results

Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a natio...
https://doi.org/10.1002/hed.26504
Head & Neck REFERENCES; Su WW, Lee YH et. al.

Oct 13th, 2020 - To assess the impact of treatment delay on survival of oral/oropharyngeal cancer (OSCC). We followed 5743 OSCCs between 2004 and 2009 from a population-based screening program and ascertained death until the end of 2012. The hazard ratios (HRs) of...

Prognostic potential of mid-treatment nodal response in oropharyngeal squamous cell car...
https://doi.org/10.1002/hed.26467
Head & Neck REFERENCES; Byun DJ, Tam MM et. al.

Sep 23rd, 2020 - We examine the prognostic implications of mid-course nodal response in oropharyngeal cancer (OPX) to radiation therapy. In 44 patients with node-positive OPX undergoing concurrent chemoradiation, nodal volumes were measured on cone beam CTs from d...

Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwi...
https://doi.org/10.1002/hed.26481
Head & Neck REFERENCES; Clark CM, Newark AC et. al.

Sep 22nd, 2020 - Single-institution studies suggest that aspirin reduces the risk of death in head and neck cancer. The aim of this study was to investigate the effect of aspirin use on overall survival (OS) in veterans with oropharyngeal cancer (OPC). A total of ...

Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous...
https://doi.org/10.1111/odi.13639
Oral Diseases REFERENCES; Bin-Alee F, Arayataweegool A et. al.

Sep 6th, 2020 - To investigate the gene expression profile of peripheral blood mononuclear cells (PBMCs) from head and neck squamous cell carcinoma (HNSCC), including oral cancer (OC) and oropharyngeal cancer (OPC) patients, and compare them with healthy controls...

Phase II study of de-intensified intensity-modulated radiotherapy and concurrent carbop...
https://doi.org/10.1002/hed.26401
Head & Neck REFERENCES; Bahig H, Lambert L et. al.

Aug 31st, 2020 - To assess cancer control and patient-reported outcomes (PROs) after de-intensified intensity-modulated radiotherapy (IMRT) in lateralized p16-associated oropharyngeal cancer (p16-OPC). Lateralized p16-OPC treated with radiotherapy and concurrent C...

see more →

News  5 results

ASCO: Deintensified treatment in p16+ oropharyngeal cancer needs evaluation
https://www.mdedge.com/hematology-oncology/article/200108/head-neck-cancers/asco-deintensified-treatment-p16-oropharyngeal?channel=39313
Caleb Rans

May 2nd, 2019 - Treatment deintensification for patients with p16+ oropharyngeal cancer (OPC) should occur only in the context of a clinical trial, according to a provisional clinical opinion released by the American Society of Clinical Oncology (ASCO). “The hypo.

HPV16 Vaccine Yields Added Benefit in Recurrent Throat Cancer
https://www.medpagetoday.com/hematologyoncology/othercancers/75474

Oct 3rd, 2018 - NEW YORK CITY -- Adding a tumor-specific vaccine to PD-1 checkpoint inhibition was safe and effective in HPV16-positive patients with recurrent or metastatic oropharyngeal cancer, a small phase II trial found. Among 24 patients treated with nivolu...

Oral Sex, Smoking Increase Men's HPV Risk
https://www.medpagetoday.com/infectiousdisease/stds/68723

Oct 23rd, 2017 - Action Points Men who smoked and had five or more lifetime oral sex partners had the highest prevalence of oral oncogenic human papilloma virus (HPV) infection (14.9%). The study suggests that even though the prevalence of infection is higher in m...

Novel Approach Reduces Treatment Toxicities in Patients With HPV-Related Oropharyngeal Cancer
https://www.onclive.com/publications/oncology-live/2017/vol-19-no-19/novel-approach-reduces-treatment-toxicities-in-patients-with-hpvrelated-oropharyngeal-cancer

Oct 4th, 2017 - Paul Dent, PhD   Surgeon Chief of Head and Neck Service Andrew S. Poklepovic, MD   Radiation Oncologist Vice Chair, Department of Radiation Oncology, Experimental Therapeutics The incidence of mouth and throat cancer is on the rise due to transmis...

HPV Persistence Predicts Poor Prognosis in Head/Neck Cancer
https://www.medscape.com/viewarticle/848854

Jul 29th, 2015 - Among patients with human papillomavirus–positive oropharyngeal cancer (HPV-OPC), persistence of HPV following treatment is associated with a poorer prognosis. Results of a new study show that the persistence of HPV16 DNA, detected in oral rinses ...

see more →

Patient Education  1 results see all →